Prisma Health announced Wednesday that it has received emergency use authorization from the U.S. Food and Drug Administration for a trademark product called VESper.Officials described it as a ventilator expansion device that allows a single ventilator to support up to four patients during times of acute equipment shortages such as the current COVID-19 pandemic. The device was produced using 3-D printing technology and developed with